Global Contraceptives Market Growth (Status and Outlook) 2026-2032
The global Contraceptives market size is predicted to grow from US$ 2008 million in 2025 to US$ 2395 million in 2032; it is expected to grow at a CAGR of 2.6% from 2026 to 2032.
In medical and regulatory contexts, the term ?contraceptives? refers to pharmaceutical and device systems that prevent pregnancy by inhibiting ovulation, altering the cervical mucus and endometrial environment, or blocking fertilization/implantation. The core paradigms include oral hormonal formulations, injectable progestins, intrauterine systems (copper or levonorgestrel-releasing devices), and emergency contraceptives. Their suitability for different populations, contraindications, and adherence management are continuously updated through evidence-based guidelines and labeling, such as the U.S. CDC?s 2024 ?Medical Eligibility Criteria for Contraceptive Use? and the EU/UK?s risk-benefit assessments and reclassification practices for combined hormonal and progestin-only products. These serve as the policy basis and technical foundation for prescription-to-nonprescription switches, pharmacy accessibility, and self-administration.
Market Opportunities and Driving Forces
Demand-side dynamics are shaped by demographics, women's fertility intentions, and awareness of reproductive health rights. Policy-side drivers primarily include national family planning initiatives and international organizational support for accessibility. Technologically, innovation is propelled by drug molecule optimization, delivery systems, and digital health solutions (e-prescriptions, follow-ups, education), enabling new adoption scenarios. Companies recognize opportunities not only in replacing or upgrading conventional oral and barrier products but also in penetrating primary healthcare markets and youth demographics through integrated services (e.g., online consultation + offline pickup). Challenges arise from regulatory disparities, long-term safety monitoring requirements, and supply chain disruptions due to cultural or policy restrictions in certain regions. To maintain trust, enterprises must integrate rigorous clinical evidence, traceable supply chains, and collaboration with public institutions to transform opportunities into sustainable growth.
Key Industry Chain: Who Captures Value?
The upstream segment involves APIs, pharmaceutical excipients, CDMOs, and prescription R&D. The midstream covers formulation, medical device manufacturing, and quality control. The downstream sector is dominated by pharmacies, hospitals, family planning programs, international philanthropic procurement, and e-commerce channels. Representative multinational R&D and channel players operate across both upstream and downstream: pharmaceutical companies lead molecular innovation and registration pathways, local drugmakers and CDMOs handle scaled production, while consumer brands (e.g., condom operators) dominate end-user education and retail systems. Downstream touchpoints are diverse and sticky, making channel integration a decisive competitive advantage. Key partners include government health programs, international organizations, and local distribution networks.
Growth Drivers in Sub-Sectors
By application and end-user, short-acting oral and barrier methods maintain steady demand among general prevention and first-time users. Long-acting reversible contraceptives (LARCs) and implant/intrauterine delivery systems are rising fastest among populations seeking long-term, intervention-free solutions. Digital prescription platforms and visual education services targeting adolescents and mobile populations are emerging as new growth frontiers. Meanwhile, premium differentiated products based on formulation innovations (e.g., novel estrogen molecules or milder hormonal combinations) and branded products emphasizing emotional/sexual wellness (e.g., functionalized condoms) are gaining rapid traction in consumption-upgrading markets. To succeed in sub-sectors, companies must simultaneously invest in clinical acceptability, user experience, and channel storytelling.
Regional Landscape: Buyers, Producers, and Trendsetters
North America is characterized by mature regulation, R&D-driven innovation, and insurance/prescription systems, where novel drugs and new indications are prioritized. China and Asia-Pacific exhibit a dual-track market: rapid expansion driven by massive grassroots demand and e-commerce penetration, alongside the need for localized channel innovations within specific cultural and regulatory contexts. Europe emphasizes public health procurement and high regulatory standards, prioritizing long-term safety monitoring and insurance coverage. Other regions are heavily influenced by international aid and NGO procurement, where policy or funding volatility directly impacts accessibility and supply stability. Collaboration between multinational corporations and international organizations, coupled with deep localization in distribution ecosystems, determines the implementation speed and resilience of regional markets.
Latest Developments
November 15, 2023: Bayer announced a two-year partnership with the UN Population Fund in India to expand reproductive health services for youth and couples through integrated digital and grassroots health systems?
February 29, 2024: Reuters reported that Reckitt (owner of Durex) is exploring live-streaming e-commerce in China to expand condom market share. Facing regulatory constraints on sexual content, the company adopted incremental livestreaming strategies to boost online sales?
August 6, 2025: Multiple media outlets cited NGO data highlighting the U.S. government's decision to handle donated contraceptive supplies, leading to the destruction of several batches. This raised concerns about aid supply chain risks and accessibility in recipient countries.
LPI (LP Information)' newest research report, the ?Contraceptives Industry Forecast? looks at past sales and reviews total world Contraceptives sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptives sales for 2026 through 2032. With Contraceptives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptives industry.
This Insight Report provides a comprehensive analysis of the global Contraceptives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Contraceptives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Contraceptives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptives and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptives.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives market by product type, application, key players and key regions and countries.
Segmentation by Type:
In medical and regulatory contexts, the term ?contraceptives? refers to pharmaceutical and device systems that prevent pregnancy by inhibiting ovulation, altering the cervical mucus and endometrial environment, or blocking fertilization/implantation. The core paradigms include oral hormonal formulations, injectable progestins, intrauterine systems (copper or levonorgestrel-releasing devices), and emergency contraceptives. Their suitability for different populations, contraindications, and adherence management are continuously updated through evidence-based guidelines and labeling, such as the U.S. CDC?s 2024 ?Medical Eligibility Criteria for Contraceptive Use? and the EU/UK?s risk-benefit assessments and reclassification practices for combined hormonal and progestin-only products. These serve as the policy basis and technical foundation for prescription-to-nonprescription switches, pharmacy accessibility, and self-administration.
Market Opportunities and Driving Forces
Demand-side dynamics are shaped by demographics, women's fertility intentions, and awareness of reproductive health rights. Policy-side drivers primarily include national family planning initiatives and international organizational support for accessibility. Technologically, innovation is propelled by drug molecule optimization, delivery systems, and digital health solutions (e-prescriptions, follow-ups, education), enabling new adoption scenarios. Companies recognize opportunities not only in replacing or upgrading conventional oral and barrier products but also in penetrating primary healthcare markets and youth demographics through integrated services (e.g., online consultation + offline pickup). Challenges arise from regulatory disparities, long-term safety monitoring requirements, and supply chain disruptions due to cultural or policy restrictions in certain regions. To maintain trust, enterprises must integrate rigorous clinical evidence, traceable supply chains, and collaboration with public institutions to transform opportunities into sustainable growth.
Key Industry Chain: Who Captures Value?
The upstream segment involves APIs, pharmaceutical excipients, CDMOs, and prescription R&D. The midstream covers formulation, medical device manufacturing, and quality control. The downstream sector is dominated by pharmacies, hospitals, family planning programs, international philanthropic procurement, and e-commerce channels. Representative multinational R&D and channel players operate across both upstream and downstream: pharmaceutical companies lead molecular innovation and registration pathways, local drugmakers and CDMOs handle scaled production, while consumer brands (e.g., condom operators) dominate end-user education and retail systems. Downstream touchpoints are diverse and sticky, making channel integration a decisive competitive advantage. Key partners include government health programs, international organizations, and local distribution networks.
Growth Drivers in Sub-Sectors
By application and end-user, short-acting oral and barrier methods maintain steady demand among general prevention and first-time users. Long-acting reversible contraceptives (LARCs) and implant/intrauterine delivery systems are rising fastest among populations seeking long-term, intervention-free solutions. Digital prescription platforms and visual education services targeting adolescents and mobile populations are emerging as new growth frontiers. Meanwhile, premium differentiated products based on formulation innovations (e.g., novel estrogen molecules or milder hormonal combinations) and branded products emphasizing emotional/sexual wellness (e.g., functionalized condoms) are gaining rapid traction in consumption-upgrading markets. To succeed in sub-sectors, companies must simultaneously invest in clinical acceptability, user experience, and channel storytelling.
Regional Landscape: Buyers, Producers, and Trendsetters
North America is characterized by mature regulation, R&D-driven innovation, and insurance/prescription systems, where novel drugs and new indications are prioritized. China and Asia-Pacific exhibit a dual-track market: rapid expansion driven by massive grassroots demand and e-commerce penetration, alongside the need for localized channel innovations within specific cultural and regulatory contexts. Europe emphasizes public health procurement and high regulatory standards, prioritizing long-term safety monitoring and insurance coverage. Other regions are heavily influenced by international aid and NGO procurement, where policy or funding volatility directly impacts accessibility and supply stability. Collaboration between multinational corporations and international organizations, coupled with deep localization in distribution ecosystems, determines the implementation speed and resilience of regional markets.
Latest Developments
November 15, 2023: Bayer announced a two-year partnership with the UN Population Fund in India to expand reproductive health services for youth and couples through integrated digital and grassroots health systems?
February 29, 2024: Reuters reported that Reckitt (owner of Durex) is exploring live-streaming e-commerce in China to expand condom market share. Facing regulatory constraints on sexual content, the company adopted incremental livestreaming strategies to boost online sales?
August 6, 2025: Multiple media outlets cited NGO data highlighting the U.S. government's decision to handle donated contraceptive supplies, leading to the destruction of several batches. This raised concerns about aid supply chain risks and accessibility in recipient countries.
LPI (LP Information)' newest research report, the ?Contraceptives Industry Forecast? looks at past sales and reviews total world Contraceptives sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptives sales for 2026 through 2032. With Contraceptives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptives industry.
This Insight Report provides a comprehensive analysis of the global Contraceptives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Contraceptives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Contraceptives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptives and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptives.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
- Online Sales
- Offline Sales
- 15?24 years
- 25?34 years
- 35?44 years
- Above 44 years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Pfizer
- Teva
- Actavis
- Gedeon Richter
- ZiZhu
- Baijingyu
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptives Market Size (2021-2032)
2.1.2 Contraceptives Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Contraceptives by Country/Region (2021, 2025 & 2032)
2.2 Contraceptives Segment by Type
2.2.1 Pills
2.2.2 Injectable
2.2.3 Condoms
2.2.4 Vaginal Rings
2.2.5 IUDs
2.2.6 Subdermal Implants
2.2.7 Others
2.2.8 Contraceptives Market Size by Type
2.2.8.1 Contraceptives Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Contraceptives Market Size Market Share by Type (2021-2026)
2.3 Contraceptives Segment by Sales Channel
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Contraceptives Market Size by Sales Channel
2.3.3.1 Contraceptives Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032)
2.3.3.2 Global Contraceptives Market Size Market Share by Sales Channel (2021-2026)
2.4 Contraceptives Segment by End User
2.4.1 15?24 years
2.4.2 25?34 years
2.4.3 35?44 years
2.4.4 Above 44 years
2.4.5 Contraceptives Market Size by End User
2.4.5.1 Contraceptives Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Contraceptives Market Size Market Share by End User (2021-2026)
3 CONTRACEPTIVES MARKET SIZE BY PLAYER
3.1 Contraceptives Market Size Market Share by Player
3.1.1 Global Contraceptives Revenue by Player (2021-2026)
3.1.2 Global Contraceptives Revenue Market Share by Player (2021-2026)
3.2 Global Contraceptives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES BY REGION
4.1 Contraceptives Market Size by Region (2021-2026)
4.2 Global Contraceptives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contraceptives Market Size Growth (2021-2026)
4.4 APAC Contraceptives Market Size Growth (2021-2026)
4.5 Europe Contraceptives Market Size Growth (2021-2026)
4.6 Middle East & Africa Contraceptives Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Contraceptives Market Size by Country (2021-2026)
5.2 Americas Contraceptives Market Size by Type (2021-2026)
5.3 Americas Contraceptives Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptives Market Size by Region (2021-2026)
6.2 APAC Contraceptives Market Size by Type (2021-2026)
6.3 APAC Contraceptives Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Contraceptives Market Size by Country (2021-2026)
7.2 Europe Contraceptives Market Size by Type (2021-2026)
7.3 Europe Contraceptives Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptives by Region (2021-2026)
8.2 Middle East & Africa Contraceptives Market Size by Type (2021-2026)
8.3 Middle East & Africa Contraceptives Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CONTRACEPTIVES MARKET FORECAST
10.1 Global Contraceptives Forecast by Region (2027-2032)
10.1.1 Global Contraceptives Forecast by Region (2027-2032)
10.1.2 Americas Contraceptives Forecast
10.1.3 APAC Contraceptives Forecast
10.1.4 Europe Contraceptives Forecast
10.1.5 Middle East & Africa Contraceptives Forecast
10.2 Americas Contraceptives Forecast by Country (2027-2032)
10.2.1 United States Market Contraceptives Forecast
10.2.2 Canada Market Contraceptives Forecast
10.2.3 Mexico Market Contraceptives Forecast
10.2.4 Brazil Market Contraceptives Forecast
10.3 APAC Contraceptives Forecast by Region (2027-2032)
10.3.1 China Contraceptives Market Forecast
10.3.2 Japan Market Contraceptives Forecast
10.3.3 Korea Market Contraceptives Forecast
10.3.4 Southeast Asia Market Contraceptives Forecast
10.3.5 India Market Contraceptives Forecast
10.3.6 Australia Market Contraceptives Forecast
10.4 Europe Contraceptives Forecast by Country (2027-2032)
10.4.1 Germany Market Contraceptives Forecast
10.4.2 France Market Contraceptives Forecast
10.4.3 UK Market Contraceptives Forecast
10.4.4 Italy Market Contraceptives Forecast
10.4.5 Russia Market Contraceptives Forecast
10.5 Middle East & Africa Contraceptives Forecast by Region (2027-2032)
10.5.1 Egypt Market Contraceptives Forecast
10.5.2 South Africa Market Contraceptives Forecast
10.5.3 Israel Market Contraceptives Forecast
10.5.4 Turkey Market Contraceptives Forecast
10.6 Global Contraceptives Forecast by Type (2027-2032)
10.7 Global Contraceptives Forecast by End User (2027-2032)
10.7.1 GCC Countries Market Contraceptives Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Contraceptives Product Offered
11.1.3 Bayer Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Contraceptives Product Offered
11.2.3 Pfizer Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Contraceptives Product Offered
11.3.3 Teva Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Actavis
11.4.1 Actavis Company Information
11.4.2 Actavis Contraceptives Product Offered
11.4.3 Actavis Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Actavis Main Business Overview
11.4.5 Actavis Latest Developments
11.5 Gedeon Richter
11.5.1 Gedeon Richter Company Information
11.5.2 Gedeon Richter Contraceptives Product Offered
11.5.3 Gedeon Richter Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Gedeon Richter Main Business Overview
11.5.5 Gedeon Richter Latest Developments
11.6 ZiZhu
11.6.1 ZiZhu Company Information
11.6.2 ZiZhu Contraceptives Product Offered
11.6.3 ZiZhu Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ZiZhu Main Business Overview
11.6.5 ZiZhu Latest Developments
11.7 Baijingyu
11.7.1 Baijingyu Company Information
11.7.2 Baijingyu Contraceptives Product Offered
11.7.3 Baijingyu Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Baijingyu Main Business Overview
11.7.5 Baijingyu Latest Developments
11.8 Sine
11.8.1 Sine Company Information
11.8.2 Sine Contraceptives Product Offered
11.8.3 Sine Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sine Main Business Overview
11.8.5 Sine Latest Developments
11.9 Reckitt
11.9.1 Reckitt Company Information
11.9.2 Reckitt Contraceptives Product Offered
11.9.3 Reckitt Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Reckitt Main Business Overview
11.9.5 Reckitt Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Contraceptives Product Offered
11.10.3 AbbVie Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 Church & Dwight
11.11.1 Church & Dwight Company Information
11.11.2 Church & Dwight Contraceptives Product Offered
11.11.3 Church & Dwight Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Church & Dwight Main Business Overview
11.11.5 Church & Dwight Latest Developments
11.12 Cooper Companies
11.12.1 Cooper Companies Company Information
11.12.2 Cooper Companies Contraceptives Product Offered
11.12.3 Cooper Companies Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cooper Companies Main Business Overview
11.12.5 Cooper Companies Latest Developments
11.13 TherapeuticsMD
11.13.1 TherapeuticsMD Company Information
11.13.2 TherapeuticsMD Contraceptives Product Offered
11.13.3 TherapeuticsMD Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 TherapeuticsMD Main Business Overview
11.13.5 TherapeuticsMD Latest Developments
11.14 Afaxys
11.14.1 Afaxys Company Information
11.14.2 Afaxys Contraceptives Product Offered
11.14.3 Afaxys Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Afaxys Main Business Overview
11.14.5 Afaxys Latest Developments
11.15 Mithra Pharmaceuticals
11.15.1 Mithra Pharmaceuticals Company Information
11.15.2 Mithra Pharmaceuticals Contraceptives Product Offered
11.15.3 Mithra Pharmaceuticals Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Mithra Pharmaceuticals Main Business Overview
11.15.5 Mithra Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptives Market Size (2021-2032)
2.1.2 Contraceptives Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Contraceptives by Country/Region (2021, 2025 & 2032)
2.2 Contraceptives Segment by Type
2.2.1 Pills
2.2.2 Injectable
2.2.3 Condoms
2.2.4 Vaginal Rings
2.2.5 IUDs
2.2.6 Subdermal Implants
2.2.7 Others
2.2.8 Contraceptives Market Size by Type
2.2.8.1 Contraceptives Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Contraceptives Market Size Market Share by Type (2021-2026)
2.3 Contraceptives Segment by Sales Channel
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Contraceptives Market Size by Sales Channel
2.3.3.1 Contraceptives Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032)
2.3.3.2 Global Contraceptives Market Size Market Share by Sales Channel (2021-2026)
2.4 Contraceptives Segment by End User
2.4.1 15?24 years
2.4.2 25?34 years
2.4.3 35?44 years
2.4.4 Above 44 years
2.4.5 Contraceptives Market Size by End User
2.4.5.1 Contraceptives Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Contraceptives Market Size Market Share by End User (2021-2026)
3 CONTRACEPTIVES MARKET SIZE BY PLAYER
3.1 Contraceptives Market Size Market Share by Player
3.1.1 Global Contraceptives Revenue by Player (2021-2026)
3.1.2 Global Contraceptives Revenue Market Share by Player (2021-2026)
3.2 Global Contraceptives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES BY REGION
4.1 Contraceptives Market Size by Region (2021-2026)
4.2 Global Contraceptives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contraceptives Market Size Growth (2021-2026)
4.4 APAC Contraceptives Market Size Growth (2021-2026)
4.5 Europe Contraceptives Market Size Growth (2021-2026)
4.6 Middle East & Africa Contraceptives Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Contraceptives Market Size by Country (2021-2026)
5.2 Americas Contraceptives Market Size by Type (2021-2026)
5.3 Americas Contraceptives Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptives Market Size by Region (2021-2026)
6.2 APAC Contraceptives Market Size by Type (2021-2026)
6.3 APAC Contraceptives Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Contraceptives Market Size by Country (2021-2026)
7.2 Europe Contraceptives Market Size by Type (2021-2026)
7.3 Europe Contraceptives Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptives by Region (2021-2026)
8.2 Middle East & Africa Contraceptives Market Size by Type (2021-2026)
8.3 Middle East & Africa Contraceptives Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CONTRACEPTIVES MARKET FORECAST
10.1 Global Contraceptives Forecast by Region (2027-2032)
10.1.1 Global Contraceptives Forecast by Region (2027-2032)
10.1.2 Americas Contraceptives Forecast
10.1.3 APAC Contraceptives Forecast
10.1.4 Europe Contraceptives Forecast
10.1.5 Middle East & Africa Contraceptives Forecast
10.2 Americas Contraceptives Forecast by Country (2027-2032)
10.2.1 United States Market Contraceptives Forecast
10.2.2 Canada Market Contraceptives Forecast
10.2.3 Mexico Market Contraceptives Forecast
10.2.4 Brazil Market Contraceptives Forecast
10.3 APAC Contraceptives Forecast by Region (2027-2032)
10.3.1 China Contraceptives Market Forecast
10.3.2 Japan Market Contraceptives Forecast
10.3.3 Korea Market Contraceptives Forecast
10.3.4 Southeast Asia Market Contraceptives Forecast
10.3.5 India Market Contraceptives Forecast
10.3.6 Australia Market Contraceptives Forecast
10.4 Europe Contraceptives Forecast by Country (2027-2032)
10.4.1 Germany Market Contraceptives Forecast
10.4.2 France Market Contraceptives Forecast
10.4.3 UK Market Contraceptives Forecast
10.4.4 Italy Market Contraceptives Forecast
10.4.5 Russia Market Contraceptives Forecast
10.5 Middle East & Africa Contraceptives Forecast by Region (2027-2032)
10.5.1 Egypt Market Contraceptives Forecast
10.5.2 South Africa Market Contraceptives Forecast
10.5.3 Israel Market Contraceptives Forecast
10.5.4 Turkey Market Contraceptives Forecast
10.6 Global Contraceptives Forecast by Type (2027-2032)
10.7 Global Contraceptives Forecast by End User (2027-2032)
10.7.1 GCC Countries Market Contraceptives Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Contraceptives Product Offered
11.1.3 Bayer Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Contraceptives Product Offered
11.2.3 Pfizer Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Contraceptives Product Offered
11.3.3 Teva Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Actavis
11.4.1 Actavis Company Information
11.4.2 Actavis Contraceptives Product Offered
11.4.3 Actavis Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Actavis Main Business Overview
11.4.5 Actavis Latest Developments
11.5 Gedeon Richter
11.5.1 Gedeon Richter Company Information
11.5.2 Gedeon Richter Contraceptives Product Offered
11.5.3 Gedeon Richter Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Gedeon Richter Main Business Overview
11.5.5 Gedeon Richter Latest Developments
11.6 ZiZhu
11.6.1 ZiZhu Company Information
11.6.2 ZiZhu Contraceptives Product Offered
11.6.3 ZiZhu Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ZiZhu Main Business Overview
11.6.5 ZiZhu Latest Developments
11.7 Baijingyu
11.7.1 Baijingyu Company Information
11.7.2 Baijingyu Contraceptives Product Offered
11.7.3 Baijingyu Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Baijingyu Main Business Overview
11.7.5 Baijingyu Latest Developments
11.8 Sine
11.8.1 Sine Company Information
11.8.2 Sine Contraceptives Product Offered
11.8.3 Sine Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sine Main Business Overview
11.8.5 Sine Latest Developments
11.9 Reckitt
11.9.1 Reckitt Company Information
11.9.2 Reckitt Contraceptives Product Offered
11.9.3 Reckitt Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Reckitt Main Business Overview
11.9.5 Reckitt Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Contraceptives Product Offered
11.10.3 AbbVie Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 Church & Dwight
11.11.1 Church & Dwight Company Information
11.11.2 Church & Dwight Contraceptives Product Offered
11.11.3 Church & Dwight Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Church & Dwight Main Business Overview
11.11.5 Church & Dwight Latest Developments
11.12 Cooper Companies
11.12.1 Cooper Companies Company Information
11.12.2 Cooper Companies Contraceptives Product Offered
11.12.3 Cooper Companies Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cooper Companies Main Business Overview
11.12.5 Cooper Companies Latest Developments
11.13 TherapeuticsMD
11.13.1 TherapeuticsMD Company Information
11.13.2 TherapeuticsMD Contraceptives Product Offered
11.13.3 TherapeuticsMD Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 TherapeuticsMD Main Business Overview
11.13.5 TherapeuticsMD Latest Developments
11.14 Afaxys
11.14.1 Afaxys Company Information
11.14.2 Afaxys Contraceptives Product Offered
11.14.3 Afaxys Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Afaxys Main Business Overview
11.14.5 Afaxys Latest Developments
11.15 Mithra Pharmaceuticals
11.15.1 Mithra Pharmaceuticals Company Information
11.15.2 Mithra Pharmaceuticals Contraceptives Product Offered
11.15.3 Mithra Pharmaceuticals Contraceptives Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Mithra Pharmaceuticals Main Business Overview
11.15.5 Mithra Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contraceptives Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Contraceptives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Injectable
Table 5. Major Players of Condoms
Table 6. Major Players of Vaginal Rings
Table 7. Major Players of IUDs
Table 8. Major Players of Subdermal Implants
Table 9. Major Players of Others
Table 10. Contraceptives Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Contraceptives Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Online Sales
Table 14. Major Players of Offline Sales
Table 15. Contraceptives Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Contraceptives Market Size by Sales Channel (2021-2026) & ($ millions)
Table 17. Global Contraceptives Market Size Market Share by Sales Channel (2021-2026)
Table 18. Contraceptives Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 20. Global Contraceptives Market Size Market Share by End User (2021-2026)
Table 21. Global Contraceptives Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Contraceptives Revenue Market Share by Player (2021-2026)
Table 23. Contraceptives Key Players Head office and Products Offered
Table 24. Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Contraceptives Market Size Market Share by Region (2021-2026)
Table 29. Global Contraceptives Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Contraceptives Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Contraceptives Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Contraceptives Market Size Market Share by Country (2021-2026)
Table 33. Americas Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Contraceptives Market Size Market Share by Type (2021-2026)
Table 35. Americas Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 36. Americas Contraceptives Market Size Market Share by End User (2021-2026)
Table 37. APAC Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Contraceptives Market Size Market Share by Region (2021-2026)
Table 39. APAC Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 41. Europe Contraceptives Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Contraceptives Market Size Market Share by Country (2021-2026)
Table 43. Europe Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 45. Middle East & Africa Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Contraceptives
Table 49. Key Market Challenges & Risks of Contraceptives
Table 50. Key Industry Trends of Contraceptives
Table 51. Global Contraceptives Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Contraceptives Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Contraceptives Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Contraceptives Market Size Forecast by End User (2027-2032) & ($ millions)
Table 55. Bayer Details, Company Type, Contraceptives Area Served and Its Competitors
Table 56. Bayer Contraceptives Product Offered
Table 57. Bayer Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Pfizer Details, Company Type, Contraceptives Area Served and Its Competitors
Table 61. Pfizer Contraceptives Product Offered
Table 62. Pfizer Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Teva Details, Company Type, Contraceptives Area Served and Its Competitors
Table 66. Teva Contraceptives Product Offered
Table 67. Teva Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Teva Main Business
Table 69. Teva Latest Developments
Table 70. Actavis Details, Company Type, Contraceptives Area Served and Its Competitors
Table 71. Actavis Contraceptives Product Offered
Table 72. Actavis Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Actavis Main Business
Table 74. Actavis Latest Developments
Table 75. Gedeon Richter Details, Company Type, Contraceptives Area Served and Its Competitors
Table 76. Gedeon Richter Contraceptives Product Offered
Table 77. Gedeon Richter Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Gedeon Richter Main Business
Table 79. Gedeon Richter Latest Developments
Table 80. ZiZhu Details, Company Type, Contraceptives Area Served and Its Competitors
Table 81. ZiZhu Contraceptives Product Offered
Table 82. ZiZhu Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ZiZhu Main Business
Table 84. ZiZhu Latest Developments
Table 85. Baijingyu Details, Company Type, Contraceptives Area Served and Its Competitors
Table 86. Baijingyu Contraceptives Product Offered
Table 87. Baijingyu Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Baijingyu Main Business
Table 89. Baijingyu Latest Developments
Table 90. Sine Details, Company Type, Contraceptives Area Served and Its Competitors
Table 91. Sine Contraceptives Product Offered
Table 92. Sine Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Sine Main Business
Table 94. Sine Latest Developments
Table 95. Reckitt Details, Company Type, Contraceptives Area Served and Its Competitors
Table 96. Reckitt Contraceptives Product Offered
Table 97. Reckitt Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Reckitt Main Business
Table 99. Reckitt Latest Developments
Table 100. AbbVie Details, Company Type, Contraceptives Area Served and Its Competitors
Table 101. AbbVie Contraceptives Product Offered
Table 102. AbbVie Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. AbbVie Main Business
Table 104. AbbVie Latest Developments
Table 105. Church & Dwight Details, Company Type, Contraceptives Area Served and Its Competitors
Table 106. Church & Dwight Contraceptives Product Offered
Table 107. Church & Dwight Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Church & Dwight Main Business
Table 109. Church & Dwight Latest Developments
Table 110. Cooper Companies Details, Company Type, Contraceptives Area Served and Its Competitors
Table 111. Cooper Companies Contraceptives Product Offered
Table 112. Cooper Companies Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Cooper Companies Main Business
Table 114. Cooper Companies Latest Developments
Table 115. TherapeuticsMD Details, Company Type, Contraceptives Area Served and Its Competitors
Table 116. TherapeuticsMD Contraceptives Product Offered
Table 117. TherapeuticsMD Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. TherapeuticsMD Main Business
Table 119. TherapeuticsMD Latest Developments
Table 120. Afaxys Details, Company Type, Contraceptives Area Served and Its Competitors
Table 121. Afaxys Contraceptives Product Offered
Table 122. Afaxys Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Afaxys Main Business
Table 124. Afaxys Latest Developments
Table 125. Mithra Pharmaceuticals Details, Company Type, Contraceptives Area Served and Its Competitors
Table 126. Mithra Pharmaceuticals Contraceptives Product Offered
Table 127. Mithra Pharmaceuticals Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Mithra Pharmaceuticals Main Business
Table 129. Mithra Pharmaceuticals Latest Developments
Table 1. Contraceptives Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Contraceptives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Injectable
Table 5. Major Players of Condoms
Table 6. Major Players of Vaginal Rings
Table 7. Major Players of IUDs
Table 8. Major Players of Subdermal Implants
Table 9. Major Players of Others
Table 10. Contraceptives Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Contraceptives Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Online Sales
Table 14. Major Players of Offline Sales
Table 15. Contraceptives Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Contraceptives Market Size by Sales Channel (2021-2026) & ($ millions)
Table 17. Global Contraceptives Market Size Market Share by Sales Channel (2021-2026)
Table 18. Contraceptives Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 20. Global Contraceptives Market Size Market Share by End User (2021-2026)
Table 21. Global Contraceptives Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Contraceptives Revenue Market Share by Player (2021-2026)
Table 23. Contraceptives Key Players Head office and Products Offered
Table 24. Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Contraceptives Market Size Market Share by Region (2021-2026)
Table 29. Global Contraceptives Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Contraceptives Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Contraceptives Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Contraceptives Market Size Market Share by Country (2021-2026)
Table 33. Americas Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Contraceptives Market Size Market Share by Type (2021-2026)
Table 35. Americas Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 36. Americas Contraceptives Market Size Market Share by End User (2021-2026)
Table 37. APAC Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Contraceptives Market Size Market Share by Region (2021-2026)
Table 39. APAC Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 41. Europe Contraceptives Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Contraceptives Market Size Market Share by Country (2021-2026)
Table 43. Europe Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 45. Middle East & Africa Contraceptives Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Contraceptives Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Contraceptives Market Size by End User (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Contraceptives
Table 49. Key Market Challenges & Risks of Contraceptives
Table 50. Key Industry Trends of Contraceptives
Table 51. Global Contraceptives Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Contraceptives Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Contraceptives Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Contraceptives Market Size Forecast by End User (2027-2032) & ($ millions)
Table 55. Bayer Details, Company Type, Contraceptives Area Served and Its Competitors
Table 56. Bayer Contraceptives Product Offered
Table 57. Bayer Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Pfizer Details, Company Type, Contraceptives Area Served and Its Competitors
Table 61. Pfizer Contraceptives Product Offered
Table 62. Pfizer Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Teva Details, Company Type, Contraceptives Area Served and Its Competitors
Table 66. Teva Contraceptives Product Offered
Table 67. Teva Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Teva Main Business
Table 69. Teva Latest Developments
Table 70. Actavis Details, Company Type, Contraceptives Area Served and Its Competitors
Table 71. Actavis Contraceptives Product Offered
Table 72. Actavis Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Actavis Main Business
Table 74. Actavis Latest Developments
Table 75. Gedeon Richter Details, Company Type, Contraceptives Area Served and Its Competitors
Table 76. Gedeon Richter Contraceptives Product Offered
Table 77. Gedeon Richter Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Gedeon Richter Main Business
Table 79. Gedeon Richter Latest Developments
Table 80. ZiZhu Details, Company Type, Contraceptives Area Served and Its Competitors
Table 81. ZiZhu Contraceptives Product Offered
Table 82. ZiZhu Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ZiZhu Main Business
Table 84. ZiZhu Latest Developments
Table 85. Baijingyu Details, Company Type, Contraceptives Area Served and Its Competitors
Table 86. Baijingyu Contraceptives Product Offered
Table 87. Baijingyu Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Baijingyu Main Business
Table 89. Baijingyu Latest Developments
Table 90. Sine Details, Company Type, Contraceptives Area Served and Its Competitors
Table 91. Sine Contraceptives Product Offered
Table 92. Sine Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Sine Main Business
Table 94. Sine Latest Developments
Table 95. Reckitt Details, Company Type, Contraceptives Area Served and Its Competitors
Table 96. Reckitt Contraceptives Product Offered
Table 97. Reckitt Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Reckitt Main Business
Table 99. Reckitt Latest Developments
Table 100. AbbVie Details, Company Type, Contraceptives Area Served and Its Competitors
Table 101. AbbVie Contraceptives Product Offered
Table 102. AbbVie Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. AbbVie Main Business
Table 104. AbbVie Latest Developments
Table 105. Church & Dwight Details, Company Type, Contraceptives Area Served and Its Competitors
Table 106. Church & Dwight Contraceptives Product Offered
Table 107. Church & Dwight Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Church & Dwight Main Business
Table 109. Church & Dwight Latest Developments
Table 110. Cooper Companies Details, Company Type, Contraceptives Area Served and Its Competitors
Table 111. Cooper Companies Contraceptives Product Offered
Table 112. Cooper Companies Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Cooper Companies Main Business
Table 114. Cooper Companies Latest Developments
Table 115. TherapeuticsMD Details, Company Type, Contraceptives Area Served and Its Competitors
Table 116. TherapeuticsMD Contraceptives Product Offered
Table 117. TherapeuticsMD Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. TherapeuticsMD Main Business
Table 119. TherapeuticsMD Latest Developments
Table 120. Afaxys Details, Company Type, Contraceptives Area Served and Its Competitors
Table 121. Afaxys Contraceptives Product Offered
Table 122. Afaxys Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Afaxys Main Business
Table 124. Afaxys Latest Developments
Table 125. Mithra Pharmaceuticals Details, Company Type, Contraceptives Area Served and Its Competitors
Table 126. Mithra Pharmaceuticals Contraceptives Product Offered
Table 127. Mithra Pharmaceuticals Contraceptives Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Mithra Pharmaceuticals Main Business
Table 129. Mithra Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Contraceptives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Contraceptives Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Contraceptives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Contraceptives Sales Market Share by Country/Region (2025)
Figure 8. Contraceptives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Contraceptives Market Size Market Share by Type in 2025
Figure 10. Global Contraceptives Market Size Market Share by Sales Channel in 2025
Figure 11. Contraceptives in 15?24 years
Figure 12. Global Contraceptives Market: 15?24 years (2021-2026) & ($ millions)
Figure 13. Contraceptives in 25?34 years
Figure 14. Global Contraceptives Market: 25?34 years (2021-2026) & ($ millions)
Figure 15. Contraceptives in 35?44 years
Figure 16. Global Contraceptives Market: 35?44 years (2021-2026) & ($ millions)
Figure 17. Contraceptives in Above 44 years
Figure 18. Global Contraceptives Market: Above 44 years (2021-2026) & ($ millions)
Figure 19. Global Contraceptives Market Size Market Share by End User in 2025
Figure 20. Global Contraceptives Revenue Market Share by Player in 2025
Figure 21. Global Contraceptives Market Size Market Share by Region (2021-2026)
Figure 22. Americas Contraceptives Market Size 2021-2026 ($ millions)
Figure 23. APAC Contraceptives Market Size 2021-2026 ($ millions)
Figure 24. Europe Contraceptives Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Contraceptives Market Size 2021-2026 ($ millions)
Figure 26. Americas Contraceptives Value Market Share by Country in 2025
Figure 27. United States Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Contraceptives Market Size Market Share by Region in 2025
Figure 32. APAC Contraceptives Market Size Market Share by Type (2021-2026)
Figure 33. APAC Contraceptives Market Size Market Share by End User (2021-2026)
Figure 34. China Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 38. India Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Contraceptives Market Size Market Share by Country in 2025
Figure 41. Europe Contraceptives Market Size Market Share by Type (2021-2026)
Figure 42. Europe Contraceptives Market Size Market Share by End User (2021-2026)
Figure 43. Germany Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 44. France Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Contraceptives Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Contraceptives Market Size Market Share by Type (2021-2026)
Figure 50. Middle East & Africa Contraceptives Market Size Market Share by End User (2021-2026)
Figure 51. Egypt Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Contraceptives Market Size 2027-2032 ($ millions)
Figure 57. APAC Contraceptives Market Size 2027-2032 ($ millions)
Figure 58. Europe Contraceptives Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Contraceptives Market Size 2027-2032 ($ millions)
Figure 60. United States Contraceptives Market Size 2027-2032 ($ millions)
Figure 61. Canada Contraceptives Market Size 2027-2032 ($ millions)
Figure 62. Mexico Contraceptives Market Size 2027-2032 ($ millions)
Figure 63. Brazil Contraceptives Market Size 2027-2032 ($ millions)
Figure 64. China Contraceptives Market Size 2027-2032 ($ millions)
Figure 65. Japan Contraceptives Market Size 2027-2032 ($ millions)
Figure 66. Korea Contraceptives Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Contraceptives Market Size 2027-2032 ($ millions)
Figure 68. India Contraceptives Market Size 2027-2032 ($ millions)
Figure 69. Australia Contraceptives Market Size 2027-2032 ($ millions)
Figure 70. Germany Contraceptives Market Size 2027-2032 ($ millions)
Figure 71. France Contraceptives Market Size 2027-2032 ($ millions)
Figure 72. UK Contraceptives Market Size 2027-2032 ($ millions)
Figure 73. Italy Contraceptives Market Size 2027-2032 ($ millions)
Figure 74. Russia Contraceptives Market Size 2027-2032 ($ millions)
Figure 75. Egypt Contraceptives Market Size 2027-2032 ($ millions)
Figure 76. South Africa Contraceptives Market Size 2027-2032 ($ millions)
Figure 77. Israel Contraceptives Market Size 2027-2032 ($ millions)
Figure 78. Turkey Contraceptives Market Size 2027-2032 ($ millions)
Figure 79. Global Contraceptives Market Size Market Share Forecast by Type (2027-2032)
Figure 80. Global Contraceptives Market Size Market Share Forecast by End User (2027-2032)
Figure 81. GCC Countries Contraceptives Market Size 2027-2032 ($ millions)
Figure 1. Contraceptives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Contraceptives Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Contraceptives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Contraceptives Sales Market Share by Country/Region (2025)
Figure 8. Contraceptives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Contraceptives Market Size Market Share by Type in 2025
Figure 10. Global Contraceptives Market Size Market Share by Sales Channel in 2025
Figure 11. Contraceptives in 15?24 years
Figure 12. Global Contraceptives Market: 15?24 years (2021-2026) & ($ millions)
Figure 13. Contraceptives in 25?34 years
Figure 14. Global Contraceptives Market: 25?34 years (2021-2026) & ($ millions)
Figure 15. Contraceptives in 35?44 years
Figure 16. Global Contraceptives Market: 35?44 years (2021-2026) & ($ millions)
Figure 17. Contraceptives in Above 44 years
Figure 18. Global Contraceptives Market: Above 44 years (2021-2026) & ($ millions)
Figure 19. Global Contraceptives Market Size Market Share by End User in 2025
Figure 20. Global Contraceptives Revenue Market Share by Player in 2025
Figure 21. Global Contraceptives Market Size Market Share by Region (2021-2026)
Figure 22. Americas Contraceptives Market Size 2021-2026 ($ millions)
Figure 23. APAC Contraceptives Market Size 2021-2026 ($ millions)
Figure 24. Europe Contraceptives Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Contraceptives Market Size 2021-2026 ($ millions)
Figure 26. Americas Contraceptives Value Market Share by Country in 2025
Figure 27. United States Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Contraceptives Market Size Market Share by Region in 2025
Figure 32. APAC Contraceptives Market Size Market Share by Type (2021-2026)
Figure 33. APAC Contraceptives Market Size Market Share by End User (2021-2026)
Figure 34. China Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 38. India Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Contraceptives Market Size Market Share by Country in 2025
Figure 41. Europe Contraceptives Market Size Market Share by Type (2021-2026)
Figure 42. Europe Contraceptives Market Size Market Share by End User (2021-2026)
Figure 43. Germany Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 44. France Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Contraceptives Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Contraceptives Market Size Market Share by Type (2021-2026)
Figure 50. Middle East & Africa Contraceptives Market Size Market Share by End User (2021-2026)
Figure 51. Egypt Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Contraceptives Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Contraceptives Market Size 2027-2032 ($ millions)
Figure 57. APAC Contraceptives Market Size 2027-2032 ($ millions)
Figure 58. Europe Contraceptives Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Contraceptives Market Size 2027-2032 ($ millions)
Figure 60. United States Contraceptives Market Size 2027-2032 ($ millions)
Figure 61. Canada Contraceptives Market Size 2027-2032 ($ millions)
Figure 62. Mexico Contraceptives Market Size 2027-2032 ($ millions)
Figure 63. Brazil Contraceptives Market Size 2027-2032 ($ millions)
Figure 64. China Contraceptives Market Size 2027-2032 ($ millions)
Figure 65. Japan Contraceptives Market Size 2027-2032 ($ millions)
Figure 66. Korea Contraceptives Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Contraceptives Market Size 2027-2032 ($ millions)
Figure 68. India Contraceptives Market Size 2027-2032 ($ millions)
Figure 69. Australia Contraceptives Market Size 2027-2032 ($ millions)
Figure 70. Germany Contraceptives Market Size 2027-2032 ($ millions)
Figure 71. France Contraceptives Market Size 2027-2032 ($ millions)
Figure 72. UK Contraceptives Market Size 2027-2032 ($ millions)
Figure 73. Italy Contraceptives Market Size 2027-2032 ($ millions)
Figure 74. Russia Contraceptives Market Size 2027-2032 ($ millions)
Figure 75. Egypt Contraceptives Market Size 2027-2032 ($ millions)
Figure 76. South Africa Contraceptives Market Size 2027-2032 ($ millions)
Figure 77. Israel Contraceptives Market Size 2027-2032 ($ millions)
Figure 78. Turkey Contraceptives Market Size 2027-2032 ($ millions)
Figure 79. Global Contraceptives Market Size Market Share Forecast by Type (2027-2032)
Figure 80. Global Contraceptives Market Size Market Share Forecast by End User (2027-2032)
Figure 81. GCC Countries Contraceptives Market Size 2027-2032 ($ millions)
